Tumor Profiling Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Projected Growth of the Tumor Profiling Market?
The market size for tumor profiling has seen fast-paced growth in the past few years. The market is set to increase from $10.16 billion in 2024 to $11.21 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. This growth for the historical period is a product of the increasing number of cancer instances, heightened demand for personalized treatment, growth in healthcare spending, wider acceptance of companion diagnostics, and a rising consciousness about the importance of early detection of cancer.

Expectations indicate a swift expansion in the tumor profiling market size in the coming years. By 2029, it is anticipated to soar to $16.48 billion with a compound annual growth rate (CAGR) of 10.1%. The predicted growth in this duration can be ascribed to the evolving adoption of liquid biopsy methodologies, amplified investment in cancer research and development, an increased aging demographic, the escalating application of targeted therapies, and a rise in collaborations in cancer research. The forecast period is likely to see some significant trends, incorporating a transition towards companion diagnostics, a surge in multi-gene testing, advancements in next-generation sequencing technology, the incorporation of artificial intelligence (AI) within cancer diagnosis, and progress in tumor profiling techniques.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24420&type=smp

What Are the Different Tumor Profiling Market Segments?
The tumor profiling market covered in this report is segmented -

1) By Technique: Genomics, Proteomics, Epigenetics, Metabolomics
2) By Technology: Sequencing Techniques, Quantitative Polymerase Chain Reaction (qPCR), Immunohistochemistry, In Situ Hybridization (ISH), Microarray
3) By Application: Personalized Cancer Medicine, Oncological Diagnostics, Research

Subsegments:
1) By Genomics: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarrays, Sanger sequencing
2) By Proteomics: Mass Spectrometry (MS), Protein Microarrays, Immunohistochemistry (IHC), Western Blotting
3) By Epigenetics: DNA Methylation Analysis, Chromatin Immunoprecipitation Sequencing (ChIP-seq), Histone Modification Profiling, Non-Coding RNA Analysis
4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy, Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), Capillary Electrophoresis-Mass Spectrometry (CE-MS)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp

What Are the Primary Drivers Shaping the Tumor Profiling Market?
The demand for customised medical treatment is likely to spur the advancement of the tumor profiling market. Personalised medicine is a healthcare approach designed specifically as per the individual qualities of each patient. The desire for highly accurate therapies with superior results and fewer side effects compared to conventional treatments is propelling this surge. Tumor profiling aids personalised medicine by pinpointing specific gene mutations and biomarkers in an individual's tumor, thereby facilitating focused treatments and minimizing side effects. For instance, a report released in February 2024 by the Personalized Medicine Coalition, an American organization promoting personalized medicine, claimed that personalised medicines made up over one-third of all novel drug approvals in 2023. This marked the fourth year in a row for this pattern. Consequently, the escalating demand for personalised medicine is catalyzing the growth of the tumor profiling market.

Which Companies Are Leading in the Tumor Profiling Market?
Major companies operating in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., Predictive Oncology Inc.

What Are the Latest Developing Trends in the Tumor Profiling Market?
Leading companies in the tumor profiling market are concentrating on introducing innovative solutions like artificial intelligence (AI)-based diagnostic tools to increase precision and efficacy in cancer care. Artificial intelligence implicates the application of sophisticated computational techniques for the analysis of intricate genomic, proteomic, and clinical data. The goal is to facilitate quicker diagnoses, tailor-made treatment plans, and improved disease progression tracking. For example, in January 2025, Panakeia Technologies LTD, a firm located in the UK that concentrates on AI-powered software for cancer diagnosis and therapy, unveiled PANProfiler Colon. This is a specialized software solution powered by AI that is targeted at profiling crucial molecular biomarkers such as MSI (microsatellite instability) and dMMR (mismatch repair deficiency) derived from H and E-stained images of colon cancer tissue samples. This electronic tool offers speedy and accurate molecular profiling of tumors, which is critical for the identification of colorectal cancer, detection of Lynch syndrome, and guiding personalized treatment choices.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report

What Are the Top Revenue-Generating Geographies in the Tumor Profiling Market?
North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Tumor Profiling Market?
2. What is the CAGR expected in the Tumor Profiling Market?
3. What Are the Key Innovations Transforming the Tumor Profiling Industry?
4. Which Region Is Leading the Tumor Profiling Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.